Show results for
Refine by
Ipsc Suppliers Serving Mauritius
30 companies found
based inMadison, WISCONSIN (USA)
BrainXell was founded in 2015 by Prof. Su-Chun Zhang in conjunction with the Discovery to Product (D2P) program of University of Wisconsin- Madison and operates out of a new facility in University Research Park. The company is based on the ...
Origin: Human iPSC line. Products: 5M Viable Cells/Vial - Standard (BX-0100). 1M Viable Cells/Vial - Standard (BX-0100e). 2M Viable Cells/Vial - GFP expressing (BX-0101). Contents: 1 vial of cells and corresponding BrainXell ...
based inBoston, MASSACHUSETTS (USA)
At Emulate, we understand that animal studies and reductionist models are limited because they are not based on integrated human biology. By leveraging 21st century technologies, we are able to overcome these limitations with living human in vitro ...
based inSeattle, WASHINGTON (USA)
Curi Bio is integrating human iPSC-derived cells, tissue-specific biosystems, and AI-enabled data analytics to accelerate the discovery of new therapeutics. Curi Bio is accelerating the discovery of the next generation of medicines by integrating ...
Curi Bio has a repository of iPSC’s for disease modeling and proprietary technologies for differentiating these cells into myoblasts and cardiomyocytes. Curi has developed in vitro 3D disease models for multiple disease ...
based inWuxi, CHINA
Established in 2009, NEST Biotechnology Co., Ltd. (NEST) is renowned for its brand 'NEST' and is dedicated to the research, development, and manufacturing of high-quality life sciences products. With a dedicated Research and Development Center and ...
based inHamburg, GERMANY
Revvity Gene Delivery (formerly SIRION Biotech) supports your cell and gene therapy development process ̶ offering solutions for early R&D all the way to clinical applications, with easy transfer of processes and assays into GMP production. ...
based inJena, GERMANY
We develop, manufacture and sell high-quality automated solutions for life sciences in a broad range of areas including molecular diagnostics, cancer and stem cell research, cell line development and bioprocessing. Our core competencies are in ...
based inWadenswil, SWITZERLAND
3Brain is the world’s first company to connect cells with sophisticated silicon chips in cell culture plates. Stemming from our passion for technology and scientific progress, our co-founders have worked for more than 15 years on CMOS-powered ...
based inSan Diego, CALIFORNIA (USA)
Since 1994, Cell Applications, Inc. has been a recognized global leader in isolation and purification of Primary Cells, and their culture in optimized, cell type-specific media. Early on, we recognized the demand for physiologically relevant, high ...
based inWaltham, MASSACHUSETTS (USA)
Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving science, with annual revenue exceeding $25 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are ...
based inMadison, WISCONSIN (USA)
Retinal degenerative diseases cause irreversible vision loss in tens of millions of patients worldwide. Our mission at Opsis Therapeutics is to advance a pipeline of first-in-class cell replacement therapies targeting Age-Related Macular ...
based inNotting Hill, AUSTRALIA
Cartherics is developing its novel “off-the-shelf” (allogeneic) immune therapy products for the treatment of cancer based on immune killer cells. The company is developing large-scale manufacture of these CAR-iNK cells for application in human ...
This technology involves induced pluripotential stem cell (iPSC) derived NK cells (and, potentially, other types of immune cells). iPSCs have unlimited capacity for ...
based inNewcastle Upon Tyne, UNITED KINGDOM
Newcells offers expert disease modelling services using best in class in vitro platforms and supports drug development by providing robust data for regulatory submissions and the critical decision-making process. Newcells mission is to de-risk the ...
A functional monolayer in vitro model of retinal pigment epithelial cells generated from human iPSCs for accurate prediction of clinical outcomes. The retinal pigment epithelial (RPE) cell model is composed of a monolayer of RPE ...
based inBremen, GERMANY
OMNI Life Science provides cutting edge solutions for cell research. Focusing on people and innovations throughout, our mission is to promote research in Life Sciences with smart, reliable and user-friendly technology. We are highly specialized on ...
based inFreiburg, GERMANY
Sartorius CellGenix is a leading global supplier of high quality raw and ancillary materials for the expanding market of cell and gene therapy and regenerative medicine. We develop, manufacture and market human cytokines, growth factors, and other ...
CellGenix® Recombinant Human EGF reliably promotes the expansion of mesenchymal stem cells (MSCs). It in addition promotes the differentiation of embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs)-derived ...
based inYokohama, JAPAN
We provide a unique combination of services and products to power your translational research. With scientists and laboratories on three continents, REPROCELL has the scientific and clinical expertise to better translate your discoveries into ...
The StemRNA 3rd Gen Reprogramming Kit provides the fastest, most efficient method for generating clinically relevant iPS cells using a non-integrating, mRNA-based protocol. This technology supports generating iPSC lines derived from ...
based inLeiden, NETHERLANDS
A leading pioneer in leveraging iPSC innovation for drug discovery. The catalyst with the requisite iPSC know-how and experience to empower innovators in drug discovery to advance their science relentlessly, consistently and efficiently. For the ...
Studying vessel formation can help identify and validate targets and candidates for treatment of a variety of diseases. Using Ncardia’s human iPSC-derived endothelial cells, we developed a capillary-on-a-chip model*, that is ...
based inAllendale, NEW JERSEY (USA)
We are a leading global contract development and manufacturing organization (CDMO) dedicated to the advancement and manufacturing of gene and cell therapy products. Minaris Regenerative Medicine is a leading global contract development and ...
based inMadison, WISCONSIN (USA)
InvivoSciences, Inc. (IVS) is a precision medicine company personalizing the drug development process by introducing patient-derived and gene-edited human samples, including 3D engineered microtissues. Our unique integration of cell & tissue ...
based inSan Francisco, CALIFORNIA (USA)
Tempo Bioscience, Inc (Tempo) develops human stem cells (human iPSC technology) based cell models and biosensor enabling technologies for preclinical drug discovery & development, biobanking, in vitro diagnostics, and biomarker development. Our ...
Blood Brain Barrier (BBB) is an important feature of the cerebral vasculature. Cells that form the barrier are called Brain Microvascular Endothelial Cells (BMECs). The barrier regulates the transport of molecular chemicals (including metabolites) ...
based inTokyo, JAPAN
Healios will expand the possibilities for curing diseases to increase and further enrich quality of life through the development and supply of regenerative medicine products as part of the rapid progress of regenerative medicine taking place in the ...
Induced pluripotent stem cells (iPSCs) are established by introducing several factors to somatic cells such as skin cells. iPSCs can differentiate into the cells of a various tissues or organs (pluripotency) and ...